Moscow — Scientists gave Russia’s Sputnik V vaccine the green light on Tuesday saying it was almost 92% effective in fighting Covid-19 based on peer-reviewed, late-stage trial results published in The Lancet international medical journal.

Experts said the phase 3 trial results means the world has another effective weapon to fight the pandemic and justifies, to some extent, Moscow’s decision to roll out the vaccine before final data has been released...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.